Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status

Overview

About this study

Do ambulatory RBC transfusions improve home functional status?

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age > 18 years
At least on prior encounter in the ambulatory infusion center
Planned RBC transfusion

Exclusion Criteria:

Refusal to provide informed consent
Refusal by the health care team
Acute ischemia (e.g. MI, CVA)
Hemoglobin < 7.0 g/dL
Active bleeding
Symptomatic anemia (hypotension, tachycardia, angina, syncope/pre-syncope believed related to anemia
Non-ambulatory functional status
Established or Uncertain Pregnancy Status

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Daryl Kor, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Daryl Kor, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials